In a year already marked by headlines of Ebola outbreaks and flashback-inducing cruise ship quarantines, everyday foodborne threats are delivering a sharp reminder of supply chain vulnerability. Since May, an ongoing cyclosporiasis outbreak that may be linked to contaminated Mexican iceberg lettuce has caused over 1,600 confirmed cases and prompted multi-state recalls.
Portfolios are commonly underexposed to the companies driving healthcare innovation. As technological disruptions build across medical fields, the ROBO Global Healthcare Technology and Innovation ETF (HTEC) provides targeted exposure to the global value chain driving this high-growth opportunity.
The artificial intelligence and robotics investment opportunity extends far beyond the headline-grabbing tech giants, offering exposure to a diverse ecosystem of enablers and application developers that many investors overlook, according to experts at VettaFi's Winter Symposium on Thursday.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Brian Clay Clay Northam Wealth Management LLC | 17,500 | $698,504.01 | $658,962.5 | -$39,541.51 | -5.66% |
Christopher C. Powers Farther Finance Advisors, LLC | 94 | $2,827.52 | $3,533.46 | $705.94 | 24.97% |
| ARCA Exchange | US Country |
The described fund is a financial investment vehicle that primarily focuses on capitalizing upon the healthcare technology sector. It commits at least 80% of its total assets to securities that are listed in an index tracking the performance of companies significantly involved in healthcare technology. This strategy is aimed at companies that show a strong potential for innovation and growth, specifically those whose products and services are gaining traction in the healthcare industry. The fund's approach is to take advantage of the evolving landscape of healthcare technology by investing in entities that stand to benefit from technological advances and market adoption of their offerings. It operates under a non-diverse investment model, concentrating its resources within the healthcare technology sector to potentially maximize returns.
The fund offers a specialized investment product focused on the healthcare technology industry. Below is an expanded view of what constitutes this offering:
The cornerstone of the fund's product offering is the investment in securities or depositary receipts that are component of an index specifically tracking companies in the healthcare technology sector. This includes publicly traded stocks of companies contributing to and leading in healthcare innovation, from medical device manufacturers to health information systems, and digital health solutions. The goal is to support and capitalize on the growth and advancements within this space.
Central to the fund’s strategy is its focus on the healthcare technology market segment. This encompasses investments in companies engaged in the development and proliferation of technology-driven healthcare solutions. It looks for businesses that not only contribute to but also benefit from the digital transformation of healthcare, including telehealth, electronic medical records (EMR), wearable health devices, and more. The fund positions itself to take advantage of the sector’s growth, driving investor value by channeling capital toward innovating companies pushing the boundaries of modern healthcare.